Literature DB >> 2873608

The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic.

D J Sanger, B Zivkovic.   

Abstract

Zolpidem is a non-benzodiazepine hypnotic drug which displaces benzodiazepines from their binding sites in different brain structures. Previous work has demonstrated several differences between zolpidem and benzodiazepines, including differences between the stimulus properties of zolpidem and chlordiazepoxide. In the present study the discriminative stimulus properties of zolpidem were analysed by training rats to discriminate between this drug and saline. It was found that stimulus control developed readily with 2 mg/kg but not with 1 mg/kg zolpidem. The effect was dose-related, had a short duration of action and was antagonised by Ro 15-1788. Furthermore, stimulus control produced by zolpidem was associated with marked reductions in rates of responding. Injections of chlordiazepoxide, triazolam, lorazepam, zopiclone, CL 218,872 and pentobarbital produced dose-related responding on the zolpidem-associated lever but haloperidol did not. However, in general, the doses of those drugs which produced drug-lever responding also reduced response rates. It is possible that the above mentioned differences between the discriminative stimulus produced by zolpidem in rats and those produced by other sedatives may be due to a selective action of zolpidem on a sub-type of benzodiazepine binding site.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873608     DOI: 10.1007/bf00174367

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Discriminative stimulus properties of benzodiazepines, barbiturates and pharmacologically related drugs; relation to some intrinsic and anticonvulsant effects.

Authors:  F C Colpaert; L K Desmedt; P A Janssen
Journal:  Eur J Pharmacol       Date:  1976-05       Impact factor: 4.432

2.  Discriminable effects of benzodiazepines.

Authors:  D A Overton
Journal:  Psychopharmacol Commun       Date:  1976

3.  Neuropharmacological specificity of the diazepam stimulus complex: effects of agonists and antagonists.

Authors:  T Haug
Journal:  Eur J Pharmacol       Date:  1983-09-30       Impact factor: 4.432

4.  CGS8216 noncompetitively antagonizes the discriminative effects of diazepam in rats.

Authors:  H E Shannon; S L Davis
Journal:  Life Sci       Date:  1984-06-25       Impact factor: 5.037

5.  State-dependent learning produced by depressant and atropine-like drugs.

Authors:  D A Overton
Journal:  Psychopharmacologia       Date:  1966

6.  Midazolam cue in rats: generalization tests with anxiolytic and other drugs.

Authors:  H S Garcha; I C Rose; I P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Lorazepam and pentobarbital discrimination: interactions with CGS 8216 and caffeine.

Authors:  N A Ator; R R Griffiths
Journal:  Eur J Pharmacol       Date:  1985-01-02       Impact factor: 4.432

8.  Specific antagonism of the behavioral effects of chlordiazepoxide and pentobarbital in the rat.

Authors:  M D Schechter
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1984       Impact factor: 5.067

9.  Generalization between benzodiazepine- and triazolopyridazine-elicited discriminative cues.

Authors:  J F McElroy; R S Feldman
Journal:  Pharmacol Biochem Behav       Date:  1982-10       Impact factor: 3.533

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  15 in total

1.  Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.

Authors:  Miroslav M Savić; Dragan I Obradović; Nenad D Ugresić; James M Cook; P V V S Sarma; Dubravko R Bokonjić
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

Review 2.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

3.  Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Evaluation of the discriminative stimulus effects of the novel sedative-hypnotic CL 284,846.

Authors:  K E Vanover; J E Barrett
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

6.  The rise (and fall?) of drug discrimination research.

Authors:  Lance R McMahon
Journal:  Drug Alcohol Depend       Date:  2015-06-01       Impact factor: 4.492

7.  Discriminative stimulus effects of omega (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system.

Authors:  D J Sanger; J Benavides
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

9.  Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic.

Authors:  J P Desager; R Hulhoven; C Harvengt; P Hermann; P Guillet; J F Thiercelin
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.

Authors:  Stephen J Kohut; Nancy A Ator
Journal:  Pharmacol Biochem Behav       Date:  2008-02-26       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.